Perceptive Advisors LLC Immatics N.V. Transaction History
Perceptive Advisors LLC
- $2.28 Billion
- Q2 2025
A detailed history of Perceptive Advisors LLC transactions in Immatics N.V. stock. As of the latest transaction made, Perceptive Advisors LLC holds 9,383,456 shares of IMTX stock, worth $54.5 Million. This represents 2.22% of its overall portfolio holdings.
Number of Shares
9,383,456
Previous 9,383,456
-0.0%
Holding current value
$54.5 Million
Previous $42.3 Million
19.29%
% of portfolio
2.22%
Previous 1.77%
Shares
5 transactions
Others Institutions Holding IMTX
# of Institutions
74Shares Held
93.6MCall Options Held
158KPut Options Held
0-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.3MShares$106 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY12MShares$69.9 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY10.2MShares$59.1 Million0.55% of portfolio
-
Rtw Investments, LP New York, NY6.97MShares$40.5 Million0.58% of portfolio
-
Vestal Point Capital, LP New York, NY6.25MShares$36.3 Million1.77% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $443M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...